How Can a Ketogenic Diet Improve Motor Function?
暂无分享,去创建一个
[1] H. Buckle,et al. [Angelman syndrome]. , 2019, Nursing RSA = Verpleging RSA.
[2] S. Masino,et al. Ketone-Based Metabolic Therapy: Is Increased NAD+ a Primary Mechanism? , 2017, Front. Mol. Neurosci..
[3] Jia Liu,et al. Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications , 2017, Front. Immunol..
[4] L. Zuo,et al. Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications , 2017, Oxidative medicine and cellular longevity.
[5] R. Swerdlow,et al. Neuroketotherapeutics: A modern review of a century-old therapy , 2017, Neurochemistry International.
[6] V. Meininger,et al. A decrease in blood cholesterol after gastrostomy could impact survival in ALS , 2017, European Journal of Clinical Nutrition.
[7] M. Mattson,et al. Effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic acid cycle intermediates and amino acids in a 3xTgAD mouse model of Alzheimer's disease , 2017, Journal of neurochemistry.
[8] C. Rae,et al. β-Hydroxybutyrate Boosts Mitochondrial and Neuronal Metabolism but is not Preferred Over Glucose Under Activated Conditions , 2017, Neurochemical Research.
[9] P. Rada,et al. A ketogenic diet modifies glutamate, gamma-aminobutyric acid and agmatine levels in the hippocampus of rats: A microdialysis study , 2017, Neuroscience Letters.
[10] C. Zeiss,et al. β-Hydroxybutyrate Deactivates Neutrophil NLRP3 Inflammasome to Relieve Gout Flares. , 2017, Cell reports.
[11] M. Cozzolino,et al. Pathways to mitochondrial dysfunction in ALS pathogenesis. , 2017, Biochemical and biophysical research communications.
[12] Robert G. Miller,et al. Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease. , 2017, The Cochrane database of systematic reviews.
[13] M. Islam. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders , 2017, Neurological research.
[14] E. Weeber,et al. Ketone ester supplementation attenuates seizure activity, and improves behavior and hippocampal synaptic plasticity in an Angelman syndrome mouse model , 2016, Neurobiology of Disease.
[15] A. Kavazis,et al. A Ketogenic Diet in Rodents Elicits Improved Mitochondrial Adaptations in Response to Resistance Exercise Training Compared to an Isocaloric Western Diet , 2016, Front. Physiol..
[16] N. Lundbom,et al. Modified Atkins diet induces subacute selective ragged‐red‐fiber lysis in mitochondrial myopathy patients , 2016, EMBO molecular medicine.
[17] D. Hovda,et al. Ketogenic diet decreases oxidative stress and improves mitochondrial respiratory complex activity , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[18] C. Kang,et al. Exercise-induced hormesis and skeletal muscle health. , 2016, Free radical biology & medicine.
[19] K. Borges,et al. Triheptanoin Protects Motor Neurons and Delays the Onset of Motor Symptoms in a Mouse Model of Amyotrophic Lateral Sclerosis , 2016, PloS one.
[20] P. Corcia,et al. Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection , 2016, Expert opinion on pharmacotherapy.
[21] M. Baudry,et al. Potential therapeutic approaches for Angelman syndrome , 2016, Expert opinion on therapeutic targets.
[22] B. Bistrian,et al. Eucaloric Ketogenic Diet Reduces Hypoglycemia and Inflammation in Mice with Endotoxemia , 2016, Lipids.
[23] J. Mahmoudi,et al. The efficacy of the ketogenic diet on motor functions in Parkinson’s disease: A rat model , 2016, Iranian journal of neurology.
[24] A. Branco,et al. Ketogenic diets: from cancer to mitochondrial diseases and beyond , 2016, European journal of clinical investigation.
[25] B. J. Turner,et al. AMPK Signalling and Defective Energy Metabolism in Amyotrophic Lateral Sclerosis , 2016, Neurochemical Research.
[26] H. Arai,et al. Clinical Interventions in Aging Dovepress , 2022 .
[27] A. Köfalvi,et al. Ketone bodies effectively compete with glucose for neuronal acetyl‐CoA generation in rat hippocampal slices , 2015, NMR in biomedicine.
[28] A. Tagliabue,et al. Short-term effects of ketogenic diet on anthropometric parameters, body fat distribution, and inflammatory cytokine production in GLUT1 deficiency syndrome. , 2015, Nutrition.
[29] S. Auvin,et al. Ketogenic diet exhibits anti‐inflammatory properties , 2015, Epilepsia.
[30] P. A. Crawford,et al. Ketone body β-hydroxybutyrate blocks the NLRP3 inflammasome-mediated inflammatory disease , 2015, Nature Medicine.
[31] T. Vanitallie,et al. A new way to produce hyperketonemia: Use of ketone ester in a case of Alzheimer's disease , 2015, Alzheimer's & Dementia.
[32] J. Rho,et al. Ketogenic diets, mitochondria, and neurological diseases , 2014, Journal of Lipid Research.
[33] Min Jung Park,et al. Anaplerotic Triheptanoin Diet Enhances Mitochondrial Substrate Use to Remodel the Metabolome and Improve Lifespan, Motor Function, and Sociability in MeCP2-Null Mice , 2014, PloS one.
[34] R. Veech. Ketone ester effects on metabolism and transcription , 2014, Journal of Lipid Research.
[35] K. Nakken,et al. Does ketogenic diet improve cognitive function in patients with GLUT1-DS? A 6- to 17-month follow-up study , 2014, Epilepsy & Behavior.
[36] P. Corcia,et al. The glutamate hypothesis in ALS: pathophysiology and drug development. , 2014, Current medicinal chemistry.
[37] T. Vanitallie,et al. Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester , 2014, Journal of Lipid Research.
[38] V. Stallings,et al. Long‐term impact of the ketogenic diet on growth and resting energy expenditure in children with intractable epilepsy , 2014, Developmental medicine and child neurology.
[39] C. Ari,et al. Metabolic Therapy with Deanna Protocol Supplementation Delays Disease Progression and Extends Survival in Amyotrophic Lateral Sclerosis (ALS) Mouse Model , 2014, PloS one.
[40] A. Bianco,et al. Ketogenic Diet in Neuromuscular and Neurodegenerative Diseases , 2014, BioMed research international.
[41] E. Génin,et al. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. , 2014, Brain : a journal of neurology.
[42] M. Tarnopolsky,et al. Mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS) may respond to adjunctive ketogenic diet. , 2014, Pediatric neurology.
[43] K. Behar,et al. The Contribution of Ketone Bodies to Basal and Activity-Dependent Neuronal Oxidation in Vivo , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[44] Ronghao Yu,et al. [A clinical trial of ketogenic diet in patients with acute spinal cord injury: safety and feasibility]. , 2014, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.
[45] H. Fuchs,et al. Mitochondrial Dysfunction and Decrease in Body Weight of a Transgenic Knock-in Mouse Model for TDP-43* , 2014, The Journal of Biological Chemistry.
[46] E. Verdin,et al. Ketone bodies as signaling metabolites , 2014, Trends in Endocrinology & Metabolism.
[47] D. Morales‐Alamo,et al. Free radicals and sprint exercise in humans , 2014, Free radical research.
[48] Brett J. Hilton,et al. Ketogenic Diet Improves Forelimb Motor Function after Spinal Cord Injury in Rodents , 2013, PloS one.
[49] P. Caroni,et al. Neuroprotection through Excitability and mTOR Required in ALS Motoneurons to Delay Disease and Extend Survival , 2013, Neuron.
[50] Qiong Wu,et al. 3-Hydroxybutyrate methyl ester as a potential drug against Alzheimer's disease via mitochondria protection mechanism. , 2013, Biomaterials.
[51] Leif Benner,et al. Ketogenic Diet Improves Motor Performance but Not Cognition in Two Mouse Models of Alzheimer’s Pathology , 2013, PloS one.
[52] J. LaManna,et al. Ketosis Proportionately Spares Glucose Utilization in Brain , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[53] Carl E Stafstrom,et al. How Does the Ketogenic Diet Work? Four Potential Mechanisms , 2013, Journal of child neurology.
[54] M. Murphy,et al. A ketogenic diet improves motor performance but does not affect β-amyloid levels in a mouse model of Alzheimer's Disease , 2013, Brain Research.
[55] S. Petri,et al. Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis , 2013, European journal of neurology.
[56] E. Wirrell,et al. Ketogenic Diet , 2013, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[57] Gary Yellen,et al. The ketogenic diet: metabolic influences on brain excitability and epilepsy , 2013, Trends in Neurosciences.
[58] U. Baxa,et al. A ketogenic diet increases brown adipose tissue mitochondrial proteins and UCP1 levels in mice , 2013, IUBMB life.
[59] G. Pasinetti,et al. Caprylic Triglyceride as a Novel Therapeutic Approach to Effectively Improve the Performance and Attenuate the Symptoms Due to the Motor Neuron Loss in ALS Disease , 2012, PloS one.
[60] M. McKenna. Substrate Competition Studies Demonstrate Oxidative Metabolism of Glucose, Glutamate, Glutamine, Lactate and 3-Hydroxybutyrate in Cortical Astrocytes from Rat Brain , 2012, Neurochemical Research.
[61] E. Thiele,et al. Low glycemic index treatment for seizures in Angelman syndrome , 2012, Epilepsia.
[62] T. Vanitallie,et al. Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects. , 2012, Regulatory toxicology and pharmacology : RTP.
[63] S. Bröer,et al. Metabolism, Compartmentation, Transport and Production of Acetate in the Cortical Brain Tissue Slice , 2012, Neurochemical Research.
[64] K. Clarke,et al. Oral 28-day and developmental toxicity studies of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate. , 2012, Regulatory toxicology and pharmacology : RTP.
[65] G. Dienel,et al. Brain Lactate Metabolism: The Discoveries and the Controversies , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[66] U. Baxa,et al. Mitochondrial biogenesis and increased uncoupling protein 1 in brown adipose tissue of mice fed a ketone ester diet , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[67] Ketogenic diets in the treatment of epilepsy , 2012, Drug and Therapeutics Bulletin.
[68] Jong M. Rho,et al. The Ketogenic Diet as a Treatment Paradigm for Diverse Neurological Disorders , 2012, Front. Pharmacol..
[69] Pierre J Magistretti,et al. Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. , 2011, Cell metabolism.
[70] A. D’Aniello,et al. Low glycemic index diet in children and young adults with refractory epilepsy: First Italian experience , 2011, Seizure.
[71] U. Sonnewald,et al. β-Hydroxybutyrate is the preferred substrate for GABA and glutamate synthesis while glucose is indispensable during depolarization in cultured GABAergic neurons , 2011, Neurochemistry International.
[72] D. Wallace,et al. Mitochondrial dysfunction in CA1 hippocampal neurons of the UBE3A deficient mouse model for Angelman syndrome , 2011, Neuroscience Letters.
[73] R. Nicoll,et al. Metabolic Control of Vesicular Glutamate Transport and Release , 2010, Neuron.
[74] M. Spilioti,et al. Ketogenic diet in a patient with Angelman syndrome , 2010, Pediatrics international : official journal of the Japan Pediatric Society.
[75] P. Stafford,et al. The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma , 2010, Nutrition & metabolism.
[76] L. Petrucelli,et al. Wild-Type Human TDP-43 Expression Causes TDP-43 Phosphorylation, Mitochondrial Aggregation, Motor Deficits, and Early Mortality in Transgenic Mice , 2010, The Journal of Neuroscience.
[77] E. Bergbower,et al. Seizure tests distinguish intermittent fasting from the ketogenic diet , 2010, Epilepsia.
[78] M. Orešič,et al. Ketogenic diet slows down mitochondrial myopathy progression in mice. , 2010, Human molecular genetics.
[79] J. Rho,et al. Ketones prevent synaptic dysfunction induced by mitochondrial respiratory complex inhibitors , 2010, Journal of neurochemistry.
[80] Bao-hua Cheng,et al. Neuroprotective and Anti-inflammatory Activities of Ketogenic Diet on MPTP-induced Neurotoxicity , 2010, Journal of Molecular Neuroscience.
[81] Shuwei Liu,et al. Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson's disease , 2009, Brain Research.
[82] L. Costantini,et al. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial , 2009, Nutrition & metabolism.
[83] E. Kossoff,et al. Empiric Use of Potassium Citrate Reduces Kidney-Stone Incidence With the Ketogenic Diet , 2009, Pediatrics.
[84] S. Heinrichs,et al. Improvement in motor and exploratory behavior in Rett syndrome mice with restricted ketogenic and standard diets , 2009, Epilepsy & Behavior.
[85] E. Ishii,et al. β-hydroxybutyrate alters GABA-transaminase activity in cultured astrocytes , 2009, Brain Research.
[86] A. Hartman,et al. The ketogenic diet: Uses in epilepsy and other neurologic illnesses , 2008, Current treatment options in neurology.
[87] L. Mascitelli,et al. DYSLIPIDEMIA IS A PROTECTIVE FACTOR IN AMYOTROPHIC LATERAL SCLEROSIS , 2008, Neurology.
[88] M. Febbraio,et al. Effect of high-frequency resistance exercise on adaptive responses in skeletal muscle. , 2007, Medicine and science in sports and exercise.
[89] I. Nissim,et al. The ketogenic diet and brain metabolism of amino acids: relationship to the anticonvulsant effect. , 2007, Annual review of nutrition.
[90] J. Rho,et al. Ketone bodies are protective against oxidative stress in neocortical neurons , 2007, Journal of neurochemistry.
[91] M. J. Marques-Dias,et al. Ketogenic diet for the treatment of refractory epilepsy: a 10 year experience in children. , 2007, Arquivos de neuro-psiquiatria.
[92] J. Rho,et al. Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation , 2007, Neuroscience.
[93] H. Heinze,et al. Metabolic progression markers of neurodegeneration in the transgenic G93A‐SOD1 mouse model of amyotrophic lateral sclerosis , 2007, The European journal of neuroscience.
[94] V. Stallings,et al. Vitamin D Status in Children with Intractable Epilepsy, and Impact of the Ketogenic Diet , 2007, Epilepsia.
[95] J. Rho,et al. Anticonvulsant Mechanisms of the Ketogenic Diet , 2007, Epilepsia.
[96] Michael A. Rogawski,et al. Neuroprotective and disease-modifying effects of the ketogenic diet , 2006, Behavioural Pharmacology.
[97] Y. Smith,et al. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet , 2006, Annals of neurology.
[98] D. Keene. A systematic review of the use of the ketogenic diet in childhood epilepsy. , 2006, Pediatric neurology.
[99] N. Siva. Can ketogenic diet slow progression of ALS? , 2006, The Lancet Neurology.
[100] Stephanie C. Licata,et al. Bioenergetic abnormalities in discrete cerebral motor pathways presage spinal cord pathology in the G93A SOD1 mouse model of ALS , 2006, Neurobiology of Disease.
[101] M. Mattson,et al. Interferon‐γ is up‐regulated in the hippocampus in response to intermittent fasting and protects hippocampal neurons against excitotoxicity , 2006, Journal of neuroscience research.
[102] D. MacGrogan,et al. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis , 2006, BMC Neuroscience.
[103] E. Thiele,et al. Atypical GLUT1 deficiency with prominent movement disorder responsive to ketogenic diet , 2006, Movement disorders : official journal of the Movement Disorder Society.
[104] A. Cnaan,et al. Fasting versus Gradual Initiation of the Ketogenic Diet: A Prospective, Randomized Clinical Trial of Efficacy , 2005, Epilepsia.
[105] L. Stamp,et al. Diet and rheumatoid arthritis: a review of the literature. , 2005, Seminars in arthritis and rheumatism.
[106] F. Rise,et al. Brain metabolism of exogenous pyruvate , 2005, Journal of neurochemistry.
[107] E. Kossoff,et al. The Ketogenic Diet , 2005, The neurologist.
[108] S. B. Heymsfield,et al. Treatment of Parkinson disease with diet-induced hyperketonemia: A feasibility study , 2005, Neurology.
[109] C. Bondy,et al. Caloric restriction augments brain glutamic acid decarboxylase‐65 and ‐67 expression , 2004, Journal of neuroscience research.
[110] J. Aronson,et al. What is a clinical trial? , 2004, British journal of clinical pharmacology.
[111] J. Rho,et al. The ketogenic diet increases mitochondrial uncoupling protein levels and activity , 2004, Annals of neurology.
[112] T. Cullingford. The ketogenic diet; fatty acids, fatty acid-activated receptors and neurological disorders. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.
[113] M. Reger,et al. Effects of β-hydroxybutyrate on cognition in memory-impaired adults , 2004, Neurobiology of Aging.
[114] E. Kossoff,et al. Efficacy of the Atkins diet as therapy for intractable epilepsy , 2003, Neurology.
[115] C. Gottfried,et al. Ketogenic Diet Increases Glutathione Peroxidase Activity in Rat Hippocampus , 2003, Neurochemical Research.
[116] M. Vila,et al. D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. , 2003, The Journal of clinical investigation.
[117] J. Rychik,et al. Selenium Deficiency Associated with Cardiomyopathy: A Complication of the Ketogenic Diet , 2003, Epilepsia.
[118] Christina Bergqvist,et al. In vivo measurement of brain metabolites using two‐dimensional double‐quantum MR spectroscopy—exploration of GABA levels in a ketogenic diet , 2003, Magnetic resonance in medicine.
[119] D. D. Fraser,et al. Elevated polyunsaturated fatty acids in blood serum obtained from children on the ketogenic diet , 2003, Neurology.
[120] G. Liebhaber,et al. Ketogenic Diet in Rett Syndrome , 2003, Journal of child neurology.
[121] M. Beal,et al. Mutated Human SOD1 Causes Dysfunction of Oxidative Phosphorylation in Mitochondria of Transgenic Mice* , 2002, The Journal of Biological Chemistry.
[122] Robert W. Taylor,et al. Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis. , 2002, Brain : a journal of neurology.
[123] Zuoshang Xu,et al. A quantitative histochemical assay for activities of mitochondrial electron transport chain complexes in mouse spinal cord sections , 2002, Journal of Neuroscience Methods.
[124] E. Schon,et al. Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients , 2002, Journal of neurochemistry.
[125] M. Guzmán,et al. Is there an astrocyte–neuron ketone body shuttle? , 2001, Trends in Endocrinology & Metabolism.
[126] Britton Chance,et al. Ketone Bodies, Potential Therapeutic Uses , 2001, IUBMB life.
[127] C. Elger,et al. Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. , 2000, Brain : a journal of neurology.
[128] K. Clarke,et al. D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[129] Naomi Aronson,et al. Ketogenic Diet for the Treatment of Refractory Epilepsy in Children: A Systematic Review of Efficacy , 2000, Pediatrics.
[130] M. Mattson,et al. 2‐deoxy‐d‐glucose protects hippocampal neurons against excitotoxic and oxidative injury: Evidence for the involvement of stress proteins , 1999, Journal of neuroscience research.
[131] Steven B Heymsfield,et al. Organ-tissue mass measurement allows modeling of REE and metabolically active tissue mass. , 1998, American journal of physiology. Endocrinology and metabolism.
[132] H. Brunengraber. Potential of ketone body esters for parenteral and oral nutrition. , 1997, Nutrition.
[133] M. Erecińska,et al. Regulation of GABA Level in Rat Brain Synaptosomes: Fluxes Through Enzymes of the GABA Shunt and Effects of Glutamate, Calcium, and Ketone Bodies , 1996, Journal of neurochemistry.
[134] M. Bixel,et al. Generation of Ketone Bodies from Leucine by Cultured Astroglial Cells , 1995, Journal of neurochemistry.
[135] Basil Künnecke,et al. Cerebral metabolism of [1,2‐13C2]glucose and [U‐13C4]3‐hydroxybutyrate in rat brain as detected by 13C NMR spectroscopy , 1993, NMR in biomedicine.
[136] N. Auestad,et al. Fatty Acid Oxidation and Ketogenesis by Astrocytes in Primary Culture , 1991, Journal of neurochemistry.
[137] O. Førre,et al. [Diet and rheumatoid arthritis]. , 1989, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.
[138] P. Huttenlocher. Ketonemia and Seizures: Metabolic and Anticonvulsant Effects of Two Ketogenic Diets in Childhood Epilepsy , 1976, Pediatric Research.
[139] H. Mcilwain. Brain Metabolism , 1973, Nature.
[140] C. Rae,et al. β-Hydroxybutyrate in the Brain: One Molecule, Multiple Mechanisms , 2016, Neurochemical Research.
[141] J. LaManna,et al. Ketones suppress brain glucose consumption. , 2009, Advances in Experimental Medicine and Biology.
[142] C. Robertson,et al. Cerebral metabolism. , 1994, Neurosurgery clinics of North America.
[143] D. Trauner,et al. Therapeutic effects of a ketogenic diet in Rett syndrome. , 1986, American journal of medical genetics. Supplement.